Archive for personal injury claims

Nationwide Surge in Pedestrian Injury Claims Linked to E-Scooter Expansion

Nationwide Surge in Pedestrian Injury Claims Linked to E-Scooter Expansion

Electric scooters have quickly become part of city life. They’re fast, affordable, and easy to rent, but they also come with a growing legal problem: pedestrian injuries. Across the country, cities are seeing a sharp increase in claims involving collisions between e-scooter riders and people walking on sidewalks or crossing streets. For pedestrians hurt in these accidents, the path to justice can be complicated.

Why are these cases rising so quickly? In many cities, scooter programs launched faster than safety rules could catch up. Riders share the same narrow spaces as pedestrians, often without helmets or clear guidance on where to ride. Some municipalities ban scooters on sidewalks, others don’t, and enforcement is inconsistent. This lack of uniform rules creates confusion that leads directly to injury.

Who is responsible when a scooter hits someone? That question depends on the situation. If a rider behaves recklessly, they can be held personally liable for medical costs, lost wages, and pain and suffering. But in other cases, fault may extend beyond the rider. Rental companies could face claims for defective brakes, poor maintenance, or failure to warn users about known risks. City governments might also be pulled into lawsuits if unsafe infrastructure contributed to the crash.

Victims often face severe injuries. E-scooter collisions can cause broken bones, concussions, facial fractures, or spinal trauma. For older adults, even a minor impact can lead to lasting complications. When the accident involves a rental scooter, determining insurance coverage becomes even harder. Many riders mistakenly believe the rental app’s terms provide coverage, only to find that the fine print excludes most claims.

Are courts treating these cases differently than car or bike collisions? Yes. Because scooters are still relatively new, legal precedents are evolving. Plaintiffs’ attorneys must often educate courts about how scooters operate and how riders are trained. Some judges view scooters like bicycles, while others see them as motorized vehicles. The distinction matters because it determines which safety laws and insurance requirements apply.

For cities, the rising number of injury claims raises financial and political concerns. Municipalities want to promote green transportation, but every lawsuit reminds them that safety must come first. Many are now revising traffic ordinances, adding dedicated scooter lanes, or requiring better reporting from rental companies. Public safety advocates are also pushing for new education campaigns so pedestrians and riders understand how to share the road responsibly.

What can victims do if they’ve been hit by a scooter? The first step is gathering evidence. Photos of the scene, witness statements, and medical records help establish what happened. Reporting the incident immediately to both the scooter company and local authorities is also important. Because liability can involve multiple parties, having clear documentation makes it easier to prove negligence and recover damages.

The expansion of e-scooters shows how innovation can move faster than regulation. These devices have changed how people travel, but safety hasn’t kept pace. Until stronger rules are in place, pedestrians will continue to bear the risk. For those already injured, legal action remains one of the only tools to demand accountability.

Lawsuits Target Heart Medicine Tainted with Cancer-Causing Chemicals

Lawsuits keep rolling in against the manufacture of a generic heart medication that has been found to be contaminated with carcinogenic chemicals. This contaminant has been on the market for a few years and has found its way into many commercial heart medications. The cancer-causing chemical known as NDMA was detected in Valsartan—an ingredient in heart medication manufactured by the company Zhejiang Huahai Pharmaceutical Co.

A lawyer looking into these cases has found over 2,000 personal injury cases linked to the contaminated medicine that may potentially sue for damages. Claims that were filed against the manufacturer have totaled over 93 million dollars. Lawyers involved in the cases have stated that it will be a difficult task to prove whether or not claimants have developed cancer due to exposure to the contaminated drug.

The FDA has been conducting a complicated recall medication contaminated by the drug since July of 2018. The FDA has claimed that drugs may have been contaminated for the last four years. The recall effort has been a complicated process of tracking down all of the different manufactures the tainted drug has been used in. The FDA has identified many of the contaminated drugs, but the process is complicated by the fact that Valsartan isn’t medicine in itself, but an ingredient used by many other companies.

So far, CVS, Mylan, Teva, and over 30 other companies have been found to have used the contaminated drug. Each of these companies has been named in at least one of the many lawsuits while Zhejiang Huahai Pharmaceutical Co. is the number one target of all of the legal proceedings. These lawsuits are still in the early stages and the outcomes of these proceedings will likely be unknown for a few years to come.

The FDA has concluded that it needs to revamp its policies and securities involving the production of these kinds of drugs. Specifically, the FDA is going to take steps to increase the safety and purity of medicines and components entering the US from foreign manufacturers—which was the case with the NDMA contaminated Valsartan. The FDA already inspected other factories with similar possible contaminations.